|
|
|
|
| LEADER |
01684nam a2200253 u 4500 |
| 001 |
EB002001279 |
| 003 |
EBX01000000000000001164180 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Pohar, Ron
|
| 245 |
0 |
0 |
|a Routine pathology for intrauterine devices and therapeutic abortion
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness, and guidelines
|c authors, Ron Pohar, Kelly Farrah
|
| 250 |
|
|
|a Version: 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c September 12, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (21 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Farrah, Kelly
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549583
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a When human tissue is removed as part of a medical procedure, the tissue may then be sent to a laboratory for examination and evaluation by a pathologist for documentation and reporting. There are costs to the healthcare system associated with processing tissues, preparing tissue for analysis, time spent examining tissue, and the time required to produce a written pathology reports. The potentially low diagnostic or clinical value of some routine pathology tests has made it unclear if it is necessary to send all tissues removed during surgery or other procedures for examination by a pathologist
|